Lapatinib Plus Caelyx in Patients With Advanced Metastatic Breast Cancer Following Failure of Trastuzumab Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00903656
Recruitment Status : Terminated (Caelyx was not available anymore)
First Posted : May 18, 2009
Last Update Posted : December 24, 2013
Information provided by (Responsible Party):
Arbeitsgemeinschaft medikamentoese Tumortherapie

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Primary Completion Date : May 2012
  Study Completion Date : May 2012